Life Extension Update
Low LDL cholesterol associated with increased cancer risk
The finding of a review reported in July 31, 2007 issue of the Journal of the American College of Cardiology questions the wisdom of widespread aggressive reduction of cholesterol to very low levels by the use of statin drugs as recommended by recent national guidelines. Although significant reduction of low-density lipoprotein (LDL) cholesterol may help prevent heart disease, researchers at Tufts University have discovered an association between decreased LDL and a greater risk of cancer.
In an effort to determine the mechanism of statin drugs’ damaging side effects, Tufts University School of Medicine professor of medicine Richard H. Karas, MD and colleagues examined data from the treatment arms of 23 randomized controlled statin drug trials that included 75,317 participants, and found that liver toxicity rose with increased dosage, leading the team to conclude that moderate dose therapy with several medications may be preferable to high dose therapy with a statin drug alone.
To examine the drugs’ effect on cancer, 13 treatment arms including 41,173 participants were evaluated. When the researchers analyzed the effect of LDL reduction on the rates of newly diagnosed cancer, they found that for every 1,000 patients with low LDL levels there was an additional incidence of cancer compared to the same amount of subjects with higher LDL. This relationship was not dependent upon the percentage of change in LDL levels, nor was the cancer limited to a specific type or location.
The authors conclude that “the cardiovascular benefits of low achieved levels of LDL cholesterol may in part be offset by an increased risk of cancer.” It is not known whether the increased risk of cancer is attributable to statin drugs or having low LDL. “This analysis doesn’t implicate the statin in increasing the risk of cancer,” Dr Karas stated. “The demonstrated benefits of statins in lowering the risk of heart disease remain clear, however, certain aspects of lowering LDL with statins remain controversial and merit further research.”
The following nutritional supplements offer synergistic benefits to assist dietary modification to reduce total serum cholesterol and elevate HDL cholesterol:
If you have questions or comments concerning this issue or past issues of Life Extension Update, send them to email@example.com or call 954 202 7716.
For longer life,
Sign up for Life Extension Update at http://mycart.lef.org/Memberships/NewsSubscription.aspx
Help spread the good news about living longer and healthier. Forward this email to a friend!
View previous issues of Life Extension Update in the Newsletter Archive.
This supplement should be taken in conjunction with a healthy diet and regular exercise program. Individual results are not guaranteed and results may vary.
The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.
If you are not 100% satisfied with any purchase made directly from Life Extension®, just return your purchase within 12 months of original purchase date and we will either replace the product for you, credit your original payment method or credit your Life Extension account for the full amount of the original purchase price (less shipping and handling).
These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.